NANOVIRICIDES, INC. — Form 10-K
Filed September 28, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 28/100
What the filing says
Anil Diwan (President/Chairman) contract extended July 1, 2026–June 30, 2027 at $400,000 base salary plus 10,204 Series A Convertible Preferred Shares (25% vesting per quarter, full vesting June 30, 2027) and $2M term life insurance ($1M to company, $1M to estate). Meeta Vyas (CFO) contract similarly extended one year at same terms but without equity detail disclosed in this exhibit. Both retain 30-day termination-at-will clauses. Auditors note substantial doubt about going concern.
Why this rating
Routine annual executive contract renewal; $400K salary is ~1.7% of $23.7M market cap; preferred share value unclear but vesting to Diwan only if employed through June 2027. Going-concern warning is separate, material concern.
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.